At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 240 enrolled
Drug / intervention
Low dose DFD07 once daily +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Evaluate the Dose-Response Relationship of the Efficacy and Safety of Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period.
In Brief
A Phase 3 clinical trial evaluating Low dose DFD07 once daily, High dose DFD07 once daily, and 2 other interventions for Actinic Keratosis (AK). Completed, enrolled 240 participants across 20 sites.
Detailed Summary
Once or twice daily 12 week treatment in patients with Actinic Keratosis randomized to treatment in one of four arms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratosis (AK)
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
First PostedApr 2017
Primary CompletionNov 2017
Study CompletionJul 2018
TodayJul 2026
First PostedApr 17, 2017
Enrollment StartFeb 14, 2017
Primary CompletionNov 13, 2017
Study CompletionJul 5, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.2 years ago
Interventions
Low dose DFD07 once dailydrug
Low dose DFD07 once daily
High dose DFD07 once dailydrug
High dose DFD07 once daily
High dose DFD07 twice dailydrug
High dose DFD07 twice daily
Placebo twice dailydrug
Placebo twice daily